Author

Kathryn Peterson

Mayo ClinicORCID 0000-0003-1793-6027Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Kathryn Peterson1 paper · University of Oregon

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Jacqueline N. Hoang· 2 shared Jiayu YeiD· 2 shared John Mark B. GubataniD· 2 shared Jorge CanasiD· 2 shared Raoul S. SojwaliD· 2 shared Sidhartha R. SinhaiD· 2 shared Stephan RogallaiD· 2 shared Touran FardeeniD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Jacqueline N. Hoang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 23, 2026

Single-cell immune repertoire atlas maps coordinated circulating adaptive immune states in inflammatory bowel disease

John Mark B. Gubatan, Jiayu Ye, Christin Lund‐Andersen…·Geir Kjetil Sandve

This study creates a single-cell immune repertoire atlas in IBD patients, revealing coordinated immune states and identifying potential therapeutic targets.

DOI 10.64898/2026.09.20.753043

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 23, 2026

Single-cell profiling reveals stromal niche and α5β1 regulation of neutrophil phenotypes in ulcerative colitis

Yuxi Zhou, Jorge Canas, Jiayu Ye…·John Mark B. Gubatan

This study uses single-cell RNA sequencing and spatial profiling to show fibroblasts influence neutrophil inflammation in UC, with 5β1 targeting reducing inflammatory responses.

DOI 10.64898/2026.09.21.753318

𝕏 PostBluesky